Optimal management of chronic cyclical pelvic pain: An evidence-based and pragmatic approach

International Journal of Women's Health

Volumn 2, Issue 1, 2010, Pages 263-277

  Won, Ha Ryun ^a   Abbott, Jason ^a  

^a ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

Chronic pain; Cyclical pelvic pain; Dysmenorrhea; Endometriosis; Nonmenstrual pelvic pain

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTIHISTAMINIC AGENT; AZATHIOPRINE; BOTULINUM TOXIN A; CORTICOSTEROID; DANAZOL; GABAPENTIN; GESTAGEN; GONADORELIN DERIVATIVE; GOSERELIN; HEPARIN; LEUPRORELIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PLACEBO; SPASMOLYTIC AGENT; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT;

ADENOMYOSIS; AMENORRHEA; BLOATING; BREAKTHROUGH BLEEDING; BREAST TENDERNESS; CAUSAL ATTRIBUTION; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DIET THERAPY; DISEASE DURATION; DOSE RESPONSE; DRUG MECHANISM; DYSMENORRHEA; ENDOMETRIOSIS; EVIDENCE BASED MEDICINE; EXCISION; FLUID RETENTION; HUMAN; HYSTERECTOMY; INJECTION SITE BLEEDING; INTERSTITIAL CYSTITIS; IRRITABLE COLON; LIBIDO DISORDER; LOW DRUG DOSE; MEDICAL HISTORY; MENOPAUSAL SYNDROME; MENSTRUAL IRREGULARITY; MIGRAINE; MUELLERIAN DUCT; MUSCLE SPASM; MYALGIA; NEURALGIA; OSTEOLYSIS; OSTEOPOROSIS; PATIENT ASSESSMENT; PELVIS PAIN SYNDROME; PHYSICAL EXAMINATION; PSYCHOSOCIAL DISORDER; REVIEW; SIDE EFFECT; SPOTTING; UTERUS MYOMA; UTERUS SYNECHIA; VASOMOTOR DISORDER; VENOUS CONGESTION; VENOUS THROMBOEMBOLISM; WEIGHT GAIN;

EID: 77957344792     PISSN: None     EISSN: 11791411     Source Type: Book Series    
DOI: 10.2147/ijwh.s7991     Document Type: Review

References (130)

1. Muse KN. Cyclic pelvic pain. Obstet Gynecol Clin North Am. 1990; 17(2):427-440.
2. Zondervan KT, Yudkin PL, Vessey MP, Dawes MG, Barlow DH, Kennedy SH. Prevalence and incidence of chronic pelvic pain in primary care: evidence from a national general practice database. Br J Obstet Gynecol. 1999;106(11):1149-1155.
3. Grace VM, Zondervan KT. Chronic pelvic pain in New Zealand: prevalence, pain severity, diagnoses and use of the health services. Aust N Z J Public Health. 2004;28(4):369-375.
4. Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87(3):321-327.
5. Barbieri R. Etiology and epidemiology of endometriosis. Am J Obstet Gynecol. 1990;162:565-567.
6. Mahmood T, Templeton A, Thompson L. Menstrual symptoms in women with pelvic endometriosis. Br J Obstet Gynaecol. 1991;98:321-327.
7. Burnett MA, Antao V, Black A, et al. Prevalence of primary dysmenorrhea in Canada. J Obstet Gynaecol Can. 2005;27(8):765-770.
8. Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol. 1982;144(6):655-660.
9. Kessel N, Coppen A. The prevalence of common menstrual symptoms. Lancet. 1963;2:61-64.
10. De Groat WCBA, Yoshimura N. Neurophysioloy of micturition and its modification in animal models of human disease. In: Maggi CA, editor. The Autonomic Nervous System. Nervous Control of the Urogenital System. Vol 3. London: Harwood Academic Publishers;1993: 227-289.
11. Bodden-Heidrich R, Kuppers V, Beckmann MW, Rechenberger I, Bender HG. Chronic pelvic pain syndrome (CPPS) and chronic vulvar pain syndrome (CVPS): evaluation of psychosomatic aspects. J Psychosom Obstet Gynecol. 1999;20(3):145-151.
12. Rapkin AJ, Kames LD, Darke LL, et al. History of physical and sexual abuse in women with chronic pelvic pain. 1990;76(1): 92-96.
13. Reinhard MJ. The Long Term Neuropsychiatric Effects of Early Trauma. Malibu, CA: Pepperdine University; 2004.
14. King PM, Myers CA, Ling FW, Rosenthal RH. Musculoskeletal factors in chronic pelvic pain. J Psychosom Obstet Gynaecol. 1991; 12:87-98.
15. Stav K, Dwyer PL, Roberts L. Pudendal neuralgia. Fact or fiction? Obstet Gynecol Surv. 2009;64(3):190-199.
16. Abbott JA, Vancaillie TG. The role of ultrasound in the management of endometriosis and pelvic pain. Aust Soc Ultrasound Med Bull. 2002; 5(1):14-19.
17. Gorell H, Cyr D, Wang K, Grer B. Rectosigmoid endometriosis: diagnosis using endovaginal sonography. J Ultrasound Med. 1989;8: 459-461.
18. Fedele L, Bianchi S, Portuese A, Borruto F, Dorta M. Transrectal ultrasonography in the assessment of rectovaginal endometriosis; endoscopic ultrasound features and clinical implications. Endoscopy. 2000;32(7): 525-530.
19. Bley KR, Hunter JC, Eglen RM, et al. The role of IP prostanoid receptors in inflammatory pain. Trends Pharmacol Sci. 1998;19:141-147.
20. Jabbour HN, Kelly RW, Fraser HM, et al. Endocrine regulation of menstruation. Endocr Rev. 2006;27:17-46.
21. Altunyurt S, Gol M, Altunyurt S, Sezer O, Demir N. Primary dysmenorrhea and uterine blood flow: a color Doppler study. J Reprod Med. 2005;50(4):251-255.
22. Dawood MY. Hormones, prostaglandin and dysmenorrhea. In: Dawood MY, editor. Dysmenorrhea. Baltimore: Williams and Wilkins; 1981:20-52.
23. Chan WY, Dawood MY, Fuchs F. Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophy- lactic treatment with ibuprofen and use of oral contraceptives. Am J Med. 1981;70:535-541.
24. Dawood MY. Primary dysmenor rhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108: 428-441.
25. Chantler I, Mitchell D, Fuller A. Diclofenac potassium attenuates dysmenorrhea and restores exercise performance in women with primary dysmenorrhea. J Pain. 2009;10(2):191-200.
26. Daniels SE, Talwalker S, Torri S, Snabes MC, Recker DP, Verburg KM. Valdecoxib, a cyclo-oxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea. Obstet Gynecol. 2002;100: 350-358.
27. Daniels S, Gitton X, Zhou W, Stricker K, Barton S. Efficacy andtolerability of Lumiracoxib 200 mg once daily for treatment of primary dysmenorrhea: results from two randomized controlled trials. J Womens Health. 2008;17(3):423-437.
28. Hendrix SL, Alexander NJ. Primary dysmenorrhoea treatment with a desogestrel-containing low dose oral contraceptive. Contraception. 2002;66(6):393-399.
29. Davis AR, Westhoff CL, O'Connell K, Callagher N. Oral contraceptives for dysmenorrhoea in adolescents girls. A randomised trial. Obstetrics Gynecol. 2005;106(1):97-104.
30. O'Herlihy C, Robinson H, De Crespigny L. Mittelschmerz is a preovulatory symptom. Br Med J. 1980;280:986.
31. Laufer MR, Goitein L, Bush M, et al. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol. 1997;10:199-202.
32. Howard F. Endometriosis and endosalpingiosis. In: Howard FM, Perry CP, Carter JE, El-Minawi AM, editors. Pelvic Pain: Diagnosis and Management. New York: Lippincott; 2000:125-150.
33. Abbott J, Hawe J, Hunter D, Holmes M, Finn P, Garry R. Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril. 2004;82:878-884.
34. Fedele L, Bianchi S, Bocciolone L, Di Nola G, Parazzini F. Pain symptoms associated with endometriosis. Obstet Gynecol. 1992;79: 767-769.
35. Porpora MG, Koninckx PR, Piazze J, Natili M, Colagrande S, Cosmi EV. Correlation between endometriosis and pelvic pain. J Am Assoc Gynecol Laparosc. 1999;6:429-434.
36. Chapron C, Barakat H, Fritel X, Dubuisson JB, Breart G, Fauconnier A. Presurgical diagnosis of posterior deep infiltrating endometriosis based on a standardized questionnaire. Hum Reprod. 2005;20(2):507-513.
37. Garry R, Clayton R, Hawe J. The effect of endometriosis and its radical laparoscopic excision on quality of life indicators. Br J Obstet Gynecol. 2000;107(1):44-54.
38. Muse K. Clinical manifestations and classification of endometriosis. Clin Obstet Gynecol. 1998;31:813-822.
39. Tokushige N, Markham R, Russell P, Fraser IS. Different types of small nerve fibres in eutopic endometrium and myometrium in women with endometriosis. Fertil Steril. 2007;88(4):795-803.
40. Bedaiwy M, Casper R. Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain. Fertil Steril. 2006;86:220-222.
41. Vercellini P, Domigliana E, Vigano P, Abbiati A, Daguiati R, Crosignani PG. Endometriosis; current and future medical therapies. Best Pract Res Clin Obstet Gynaecol. 2008;22:275-306.
42. Telimaa S, Puolakka J, Ronnberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol. 1987;1:13-23.
43. Vercellini P, Cortesi I, Crosignani PG. Progestins for symptomatic endometriosis: a critical analysis of evidence. Fertil Steril. 1997;68: 393-401.
44. Razzi S, Luisi S, Calonaci F, Altomare A, Bocchi C, Petraglia F. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril. 2007;88:789-794.
45. Rock J, Truglia J, Caplan R; for the Zoladex endometriosis study group. Zoladex in the treatment of endometriosis: a randomised comparison with danazol. Obstet Gynecol.1993;82:198-205.
46. Adamson G, Subak C, Pasta D, Hurd S, von Franque O, Rodriguez B. Comparison of CO2 laser laparoscopy with laparotomy for treatment of endometriomata. Fertil Steril. 1992;67:965-973.
47. Anaf V, Simon P, Nakadi I, et al. Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod. 2000;15(8):1744-1750.
48. Wright J. The diagnosis and management of infiltrating nodular rectovaginal endometriosis. Curr Opin Obstet Gynecol. 2000;12:283-287.
49. Abbott JA, Hawe JA, Clayton R, Garry R. The effects and effectiveness of laparoscopic excision of endometriosis; a prospective study with 2-5 year follow-up. Hum Reprod. 2003;18(9):1922-1927.
50. Sutton CJG, Ewen SP, Whitelaw N, Haines P. Prospective, randomized double blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril. 1994;62:696-700.
51. Jarrell J, Mohindra R, Ross S, Taenzer P, Brant R. Laparoscopy and reported pain among patients with endometriosis. J Obstet Gynaecol Can. 2005;27:474-485.
52. Doyle JB. Paracervical uterine denervation by transection of the cervical plexus for the relief of dysmenorrhoea. Am J Obstet Gynecol. 1955;70:1.
53. Ewen SP, Sutton CJG. A combined approach to painful heavy periods: laparoscopic laser uterine nerve ablation and endometrial resection. Gynaecol Endosc. 1994;3(3):167-168.
54. Feste JR. Laser laparoscopy: a new modality. J Reprod Med. 1985;30: 413-417.
55. Chen FP, Soong YK. The effi{ligature}cacy and complications of laparoscopic presacral neurectomy in pelvic pain. Obstet Gynecol. 1997;90(6): 974-975.
56. Sutton C, Pooley AS, Jones KD, Dover RW, Haines P. A prospective, randomized, double-blind controlled trial of laparoscopic uterine nerve ablation in the treatment of pelvic pain associated with endometriosis. Gynaecol Endosc. 2001;10(4):217-222.
57. McElin TW, Bird CC. Adenomyosis of the uterus. Obstet Gynecol Annu. 1974;3:425.
58. Dueholm M, Lundorf E, Hansen ES, Sorensen JS, Ledertoug S, Olesen F. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis. Fertil Steril. 2001;76:588-594.
59. Bazot M, Cortez A, Darai E, et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod. 2001;16:2427-2433.
60. Sheng J, Zhang WY, Zhang JP, Lu D. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception. 2009;79(3): 189-193.
61. Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update. 1998;4(4):323-336.
62. McCausland V, McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update. 1998;4(4):350-359.
63. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100-107.
64. Ferrero S, Abbamonte LH, Giordano M, Parisi M, Ragni N, Remorgida V. Uterine myomas, dyspareunia, and sexual function. Fertil Steril. 2006;86(5):1504-1510.
65. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002;186(3):409-415.
66. Carlson KJ, Miller BA, Fowler FJ Jr. The Maine Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol. 1994; 83(4):566-572.
67. Wortman M, Daggett A. Hysteroscopic endocervical resection. J Am Assoc Gynecol Laparosc. 1996;4:63-68.
68. Luesley DM, Williams DR, Gee H, Chan KK, Jordan JA. Management of post-conization cervical stenosis by laser vaporization. Obstet Gynecol. 1986;67:126-128.
69. Kodaman PH, Arici A. Intra-uterine adhesions and fertility outcome: how to optimize success? Curr Opin Obstet Gynecol. 2007;19:207-214.
70. Thomson AJ, Abbott JA, Deans R, Kingston A, Vancaillie TG. The management of intrauterine synechiae. Curr Opin Obstet Gynecol. 2009;21(4):335-341.
71. Deans R, Abbott J. A review of intrauterine adhesions. J Min Invasive Gynecol. In press 2010.
72. Townsend DE, McCausland VM, McCausland AM. Post-ablation tubal sterilization syndrome. Obstet Gynecol. 1993;82:422-424.
73. McCausland AM, McCausland VM. Frequency of symptomatic cornual hematometra and postablation tubal sterilization syndrome after total rollerball endometrial ablation: a 10 year follow-up. Am J Obstet Gynecol. 2002;186(6):1274-1280.
74. Li S, Qayyum A, Coakley FV, Hricak H. Association of renal agenesis and mullerian duct anomalies. J Comp Ass Tomogr. 2000;24(6):829-834.
75. Dekel A, Efrat Z, Orvieto R, et al. The residual ovary syndrome: a 20-year experience. Eur J Obstet Gynecol Reprod Biol. 1996;68(1):159-164.
76. Beard RW, Reginald PW, Wadsworth J. Clinical features of women with chronic lower abdominal pain and pelvic congestion. Br J Obstet Gynaecol. 1988;95:153-161.
77. Rozenblit AM, Ricci ZJ, Tuvia J, Amis ES Jr. Incompetent and dilated ovarian veins: a common CT finding in asymptomatic parous women. AJR Am J Roentgenol. 2001;176(1):119-122.
78. Christensen J, Boldsen J, Westergaard J. Functional ovarian cysts in premenopausal and gynecologically healthy women. Contraception. 2002;66:153-157.
79. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980;138:880-892.
80. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory diseases: results from the PID evaluation and clinical health (PEACH) randomized trial. Am J Obstet Gynecol. 2002;186:929-937.
81. Laufer MR, Heerema AE, Parsons KE, Barbieri RL. Endosalpingiosis: clinical presentation and follow-up. Gynecol Obstet Invest. 1998;46(3):195-198.
82. Jones R, Lydeard S. Irritable bowel syndrome in the general population. Br Med J. 1992;304:87-90.
83. Talley N, Zinsmeister A, van Dyke C, Melton L. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 1991;101:927-934.
84. Sandler R. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology. 1990;99:409-415.
85. Zondervan K, Yudkin P, Vessey M, et al. Chronic pelvic pain in the community symptoms, investigations, and diagnoses. Am J Obstet Gynecol. 2001;184:1149-1155.
86. Williams RE, Hartmann KE, Sandler RS, Miller WC, Steege JF. Prevalence and characteristics of irritable bowel syndrome among women with chronic pelvic pain. Obstet Gynecol. 2004;104(3):452-458.
87. We W, Cheskin L, Heller B, et al. Evidence for exacerbation of irritable bowel syndrome during menses. Gastroenterology. 1990;98: 1485-1489.
88. Moore J, Barlow DH, Jewell D, Kennedy SH. Do gastrointestinal symptoms vary with the menstrual cycle? Br J Obstet Gynaecol. 1998;105:1322-1325.
89. Crowell M, Dubin N, Robinson J, et al. Functional bowel disorders in women with dysmenorrhea. Am J Gastroenterol. 1994;89:1973-1977.
90. Longstreth G, Preskill D, Youkeles L. Irritable bowel syndrome in women having diagnostic laparoscopy or hysterectomy. Dig Dis Sci. 1990;35:1285-1290.
91. Cash BD, Chey WD. Irritable bowel syndrome - an evidence- based approach to diagnosis. Aliment Pharmacol Ther. 2004;19:1235-1245.
92. Longstreth GF. Definition and classification of irritable bowel syndrome: current consensus and controversies. Gastroenterol Clin North Am. 2005;34:173-187.
93. Nanda R, James R, Smith H, Dudley CR, Jewell DP. Food intolerance and the irritable bowel syndrome. Gut. 1989;30:1099-1104.
94. Jaiwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med. 2000;133:136-147.
95. Gale JD. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation. Adv Ther. 2009;26(5):519-530.
96. Koziol JA, Clark DC, Gittes RF, Tan EM. The natural history of interstitial cystitis: a survey of 374 patients. J Urol. 1993;149:465-469.
97. Parsons CL. Interstitial cystitis: clinical manifestations and diagnostic criteria in over 200 cases. Neurourol Urodyn. 1990;9:241-250.
98. Lentz GM, Bavendam T, Stenchever MA, Miller JL, Smalldridge J. Hormonal manipulation in women with chronic, cyclic irritable bladder symptoms and pelvic pain. Am J Obstet Gynecol. 2002;186: 1268-1271.
99. Parsons CL, Dell J, Stanford EJ, et al. The prevalence of interstitial cystitis in gynaecologic patients with pelvic pain, as detected by intravesical potassium sensitivity. Am J Obst Gynecol. 2002;187(5): 1395-1400.
100. Haggerty CL, Schulz R, Ness RB. PID evaluation and clinical health study investigators. Lower quality of life among women with chronic pelvic pain after pelvic inflammatory disease. Obstet Gynecol. 2003;102:934-939.
101. Sant GR, Hanno PM. Intersitial cystitis: current issues and controversies in diagnosis. Urology. 2001; 57, Suppl 6A: 82-88.
102. Hanno P. Is the potassium sensitivity test a valid and useful test for the diagnosis of interstitial cystitis? Int Urogynecol Pelvic Floor Dysfunct. 2005;16:428.
103. Baker PK. Musculoskeletal origins of chronic pelvic pain. Diagnosis and treatment. Obstet Gynecol Clin North Am. 1993;20: 719-742.
104. Prendergast SA, Weiss JM. Screening for musculoskeletal causes of pelvic pain. Clin Obstet Gynecol. 2003;46:773-782.
105. Haugstad GK, Haugstad TS, Kirste UM, et al. Posture, movement patterns, and body awareness in women with chronic pelvic pain. J Psychosom Res. 2006;61:637-644.
106. Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Physician. 2002;65(4):653-660.
107. McDonald JS, Elliott ML. Gynecologic pain syndromes. In: Loeser JD, Butler SH, Champman CR, editors. Bonica's Management of Pain. 3rd ed. Philadephia: Lippincott Williams and Wilkins. 2001:1414-1447.
108. Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaillie TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol. 2006;108(4): 915-923.
109. Abbott J. Botulinum toxin in the female pelvis - a new answer to old problems? J Min Invasive Gynaecol. 2009;16(2):130-135.
110. Shafik A. Pudendal canal syndrome as a cause of vulvodynia and its treatment by pudendal nerve decompression. Eur J Obstet Gynecol Reprod Biol. 1998;80:215-220.
111. Labat JJ, Riant T, Robert R, et al. Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourol Urodyn. 2008;27:306-310.
112. Harlow BL, Wise LA, Stewart EG. Prevalence and predictors of chronic lower genital tract discomfort. Am J Obstet Gynecol. 2001; 185:545-550.
113. Bergeron S, Bouchard C, Fortier M, et al. The surgical treatment of vulvar vestibulitis syndrome: a follow-up study. J Sex Marital Ther. 1997;23:317-325.
114. Friedrich EG Jr. Vulvar vestibulitis syndrome. J Reprod Med. 1987;32:110-114.
115. Goetsch MF. Vulvar vestibulitis: prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol. 1991; 164:1609-1614.
116. Westrom L, Willen R. Vestibular nerve proliferation in vulvar vestibulitis syndrome. Obstet Gynecol. 1998;91:572-576.
117. Edwards L. New concepts in vulvodynia. Am J Obstet Gynecol. 2003;189:S24-S40.
118. Bergeron S, Binik YM, Khalife S, et al. A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain. 2001;91:297-306.
119. Granot M, Zimmer EZ, Friedman M, et al. Association between quantitative sensory testing, treatment choice, and subsequent pain reduction in vulvar vestibulitis syndrome. J Pain. 2004;5:226-232.
120. Vercellini P, De Giorgi O, Oldani S, Cortesi I, Panazza S, Crosignani PG. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis. Am J Obstet Gynecol. 1996;175(2):396-401.
121. Petta CA, Ferriani RA, Abrao, et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod. 2005;20(7):1993-1998.
122. Mathias JR, Clench MH, Reeves-Darby VG. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study. Dig Dis Sci. 1994;39(6): 1155-1162.
123. Kames LD, Rapkin AJ, Naliboff BD, Afifi S, Ferrer-Brechner T. Effectiveness of an interdisciplinary pain management program for the treatment of chronic pelvic pain. Pain. 1990;41: 41-46.
124. Butrick CW. Chronic pelvic pain: How many surgeries are enough? Clin Obstet Gynecol. 2007;50(2):412-424.
125. Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani P. A gonadotropin-releasing hormone agonist versus a lowdose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril. 1993;60(1):75-79.
126. Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N. Low-dose oral contraceptive pill for dysmenorrheal associated with endometriosis: a placebo-controlled double-blind, randomized trial. Fertil Steril. 2008;90(5):1583-1588.
127. Gregoriou O, Konidaris S, Vitoratos N, Papadias C, Papoulias I, Chryssicopoulos A. Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial. Int J Fertil Womens Med. 1997;42(6): 406-411.
128. Wright J, Lotfallah H, Jones K, Lovell D. A randomized trial of excision versus ablation for mild endometriosis. Fertil Steril. 2005; 83(6):1830-1836.
129. Ling FW. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Obstet Gynecol. 1999;93(1):51-58.
130. Keltz MD, Gera PS, Olive DL. Prospective randomized trial of right- sided paracolic adhesiolysis for chronic pelvic pain. J Soc Lap Surg. 2006;10(4):443-446.